📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma. (2023)

First Author: Arang N

Attributed to: Understanding Signalling Pathways Mutated in Inherited Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2023.101244

PubMed Identifier: 37858338

Publication URI: http://europepmc.org/abstract/MED/37858338

Type: Journal Article/Review

Volume: 4

Parent Publication: Cell reports. Medicine

Issue: 11

ISSN: 2666-3791